4d Pharma Share Discussion Threads

[amaretto1] 27/6/2022 10:45

Anyone with a trusted close link to large brokers ....Find out if they were lending stock ... and crucially who to ? Very important. Forward any information to administrators !

[stonerrj] 27/6/2022 10:33

Some good logic in your posts above Yas. Quite a few people are saying they didn't go through the detail of the OF deal with a tooth comb - perhaps including yourself back in the day(?), but I think ALL can now see just how bad it was, or at least how bloody risky it was.

As you know I have felt very suspicious about the trading patterns and the fall of the share price since around the time that deal was inked.

I've asked others on here what they think. Some have said they don't deem it suspicious. But given how explicit 4d's requirement was to raise X amount after inking that loan, obviously the health of the share price would become immediately paramount.

It therefore makes me wonder if a hostile force had seen the terms of that deal and recognised with a demolished share price the company would be at a real risk. The company has released good data over the past year - the kind of data that would normally set aim on fire in better times - but at every step we've seen cold water poured onto the share price Many of us have watched the trading here on a daily basis. We see the AT blocks coming in at opportune times, the often small rallies in the morning replaced by AT suppression seen late pm. These had become regular patterns.

And of course, lest we forget, we had a named significant shareholder dribbling, what was it, 10% of the issued share capital INTO THE MARKET over many, many months. In my personal opinion, that stank at the time and it still stinks now. I raised my concerns about this very issue repeatedly on this thread and questioned if this selling into the market and the manner in which it was being done, was by design or necessity. I think some of you even emailed the BOD to ask if it wasn't possible for that stock to be sold / transferred off market. I'm not sure if we got any answer as to if any approach had been made to place that stock, sensibly, with a buyer or even if there was any reasonable communication with the seller.

All that said, the trend in 4D's sp, closely mirrors the index to be fair and that of its peers, albeit 4D had produced better data than many of them and looked more compelling, clinically.

So just what DID 4d have lined up in order to make the 'reasonable expectation' remark in early April (the 1st no less!). The latest RNS states that, in regards to funding, good progress had been made......but ha...who knows what to believe here any more.

I rewatched the latest IG Jeremy Naylor interview over weekend and again listened carefully to what was said in that, because interestingly the issue of the OF loan was raised specifically by Naylor.

Fundamentally I think sh's need to ask were they kept properly up to date with any significant aspect that would have a material impact on the business......this would include any delays to the clinical pipeline and/or the sourcing of adequate funds sufficient that the terms of our OF loan were met (including the necessity to raise monies and/or to maintain the relevant balance within the coffers).

AIMO only.

[amaretto1] 27/6/2022 10:05

Again ..... but so be it !!

[amaretto1] 27/6/2022 10:05

The Shorters spiked the share price on M518 results ..... they were in the know !! Any proof of OF and SO being behind this is highly ilegal ....It's a conflict of interest.. and is only a instrument conceived to do damage to a SEC Nasdaq listed equity!! The SEC are far far more helpful with this situation than the AIM nomads. This is NOT over !! Didn't want a Crystal Amber situation

[podium] 27/6/2022 10:01

Those subsidiaries will be shells with negligible assets.

[amaretto1] 27/6/2022 10:00

Not one person mentioned the Oxford financeing deal before suspension...Not one ... I've scrolled back months. Before suspension NO one had accurate information and didn't frankly have a clue what was going on .. apart from odviously those behind the large shorting activities covered up by the SO selling fasard !! The volumes on suspension day were paltry ... Nobody had a clue !!!

[blueblood] 27/6/2022 09:58

The final results RNS was put out with comments such as 'sees itself well funded'. What the f were the BoD doing about managing cashflow. Advertising new jobs and starting trials etc. The trading in US on 23rd Match needs to be examined by FCA/SFO as we appear to have been wrongfully traded and even trading insolvently in last few weeks?

[thefartingcommie] 27/6/2022 09:54

Administrators appointed at listed pharmaceutical firm
27 Jun 2022 Yorkshire Business, Deals, Manufacturing
Administrators appointed at listed pharmaceutical firm

A listed pharmaceutical company has called in administrators following an unsuccessful fundraise.

James Clark and David Pike from Interpath Advisory were appointed as joint administrators to 4D Pharma plc on Friday (24 June 2022).

Headquartered in Leeds and listed on both AIM and NASDAQ, the pharmaceutical company is focused on the development of live biotherapeutics, an emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.

The business has six clinical programs underway, including therapeutic trials for conditions including cancer, asthma and Parkinson's Disease.

It has a number of subsidiaries, which are currently not subject to an insolvency process, with facilities in Scotland, Ireland, Spain, and the US.

4D Pharma recently embarked on a fundraising exercise to support its growth. However, with significant uncertainty currently affecting the global capital markets, the company was ultimately unable to progress the fundraise sufficiently quickly.

Against this backdrop, and with the company requiring significant cash to fund day-to-day trading, secured lender Oxford Finance found it necessary to take action to protect its collateral, and subsequently sought the appointment of joint administrators.

James Clark, managing director at Interpath Advisory and joint administrator, said: "Since its inception, 4D Pharma has been at the forefront of innovation around the development and use of live biotherapeutic products, but unfortunately has been impacted by the growing uncertainty gripping the capital markets.

"Our intention is to try to stabilise the company in the immediate term whilst we assess options for the business. We would encourage any parties interested in acquiring the business to contact us at the earliest opportunity. At this stage, 4D Pharma plc's subsidiaries remain outside of an insolvency process and continue to trade."

In a statement, 4D Pharma's board said it "intends to work with the joint administrators on proposals to rescue the company as a going concern, albeit there can be no guarantee that this will be successful".

The company's shares were suspended from trading on AIM on Friday (24 June).

...It has a number of subsidiaries, which are currently not subject to an insolvency process, with facilities in Scotland, Ireland, Spain, and the US...????

hmmm....

[fatgreek] 27/6/2022 09:28

Sad isn't it

[tyler90] 27/6/2022 09:08

Leaving aside what has occurred there are some really nasty human beings around who take pleasure in seeing others hurt/lose/distressed etcIt is money after all and that comes and goes and hopefully, all who have lost in this situation will get over it However, those individuals who get a kick out of it, they must lead a really sad life

[buy2sell1] 27/6/2022 07:06

TOTAL WIPE OUT FOR dddd SHAREHOLDFERS
======================================

[tazerface] 27/6/2022 06:51

ZERO pence

[georgethefourth] 27/6/2022 01:22

Yasx - agree completely. If they need to raise $45m, with or without the OF loan, then that loan serves no purpose. None of it adds up

[pwhite73] 27/6/2022 00:08

amaretto1 - "Well we have a 6 month window"

Not true if it is the intention of the administrators to recapitalise the company through the issuance of equity the suspension can last for as long as necessary. ICON was suspended on 04/06/2021 it is still suspended as the administrators try to thrash out a CVA.

[one_frankel] 26/6/2022 23:00

Mahmood sorry I meant BoxerMugz, ain't it that time for those late night Uber food deliveries double pay and all that or maybe try and entice a ji_hadi wife whilst delivering who could assist with ones ongoing fantasising, hehe!

[one_frankel] 26/6/2022 22:58

Keep up with fantasising Mahmood sorry BoxerDogz, except noones actually interested in a blatant fra_ud but why don't you tell the masses how you tried to deceive investors on the Pires thread with all your fantasising as renowned investor Stephen Jones but we soon discovered that you're not and are just an unfortunate fra_ud from the shanty towns of Birmingham, aren't you?

...Ohh by the way, I thought I was filtered as you've stated on a countless number of times Mahmood but surely not more fantasising again from a fu_ckin blatant fra_ud hey.

[buy2sell1] 26/6/2022 21:44

ANOTHER SET OF RAMPING CLOWNS & LOSERS BITE THE DUST !!!
=====================================================



4d Pharma has gone into administration and that is likely to wipe out hundreds of small shareholders (that ignored all the danger signals and didn't sell, sell, sell)

4d Pharma previously took out a $30 million loan with Oxford Finance, handing all its assets over as collateral.

However, the lender has now called in administrators from Interpath Advisory.


Amaretto1 + Sceptical Investor + Millennial Investor + milliecusto have all gone into hiding now !!!

[one_frankel] 26/6/2022 21:15

In a small private company yes but not in a similarly listed one buddy.

[amaretto1] 26/6/2022 21:11

Never mind the other leads .. one backed by the Michael j fox foundation.... etc etc ... A incredible despicable situation !! We all agree

[amaretto1] 26/6/2022 21:09

You have to remember...M518 if gets thru phase 3 trials .. your looking at a 1 billion plus drug Merk is well aware of this. A lesser drug was sold for 1.6 billion only last week ...80 million was raised in this space 2 weeks ago ... Seres have raised more cash on Friday from Nestle.... We employ 100 quality personnel...R we going under for a paltry 13 million ??

[nigelpm] 26/6/2022 21:01

having worked in small businesses and large corporates I can tell you it's highly unlikely in a small business - not impossible but unlikely. CEO gets involved in everything generally.